Uridine-13C9,15N2
Uridine-13C9,15N2 (β-Uridine-13C9,15N2) is 13C and 15N labeled Uridine (HY-B1449) . Uridine is a glycosylated pyrimidine-analog containing uracil attached to a ribose ring (or more specifically, aribofuranose) via a β-N1-glycosidic bond[1].
Product Specifications
CAS Number
[202406-84-6]
Product Name Alternative
β-Uridine-13C9,15N2
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite; Isotope-Labeled Compounds; Nucleoside Antimetabolite/Analog
Type
Isotope-Labeled Compounds
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/uridine-13c9-15n2.html
Concentration
100 mM * 0.039 mL in Water
Purity
99.0
Solubility
10 mM in DMSO
Smiles
O[13C@H]1[13C@@H](O)[13C@H]([15N]2[13C]([15NH][13C]([13CH]=[13CH]2)=O)=O)O[13C@@H]1[13CH2]O
Molecular Formula
13C9H12 15N2O6
Molecular Weight
255.12
Precautions
H302, H315, H319, H335
References & Citations
[1]G P Connolly, et al. Uridine and its nucleotides: biological actions, therapeutic potentials. Trends Pharmacol Sci. 1999 May;20 (5) :218-25.
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PPIAL4A, ID (PPIAL4A, COAS2, Peptidyl-prolyl cis-trans isomerase A-like 4A/B/C, Chromosome 1-amplified sequence 2, Cyclophilin homolog overexpressed in liver cancer) (MaxLight 490)